-
WEI CHEN
Beijing
PROFILE REPRESENTATIVE MATTERS AND CASES OTHER INFORMATION Further Reading
MS. CHEN SPECIALIZES IN CORPORATE FINANCE, INCLUDING M&A, VENTURE CAPITAL AND PRIVATE EQUITY.
Education
Boston University School of Law, Boston, Massachusetts, J.D.
Peking University School of Law, Beijing, LL.B
Professional Qualification
Admitted to practice in New York
Admitted to practice in Massachusetts (currently inactive)
Registered Foreign Lawyer in Hong Kong SAR
Work Language
English
Mandarin
Cantonese
Professional Background
Ms. Chen joined Fangda Partners in 2017. Before joining the firm, she worked at major law firms, including Linklaters LLP and Paul, Weiss, Rifkind, Wharton & Garrison LLP in both Beijing and Hong Kong. She has been recognized by Asialaw’s “Leading Lawyers 2009” as a leading lawyer in venture capital and private equity.
PROFILE
REPRESENTATIVE MATTERS AND CASES
- Acted for IDG-Accel in its investments in various industries including TMT, logistics, new energy, graphene technology, micro-lending, second-hand car platforms, real estate management, group shopping and sports broadcasting
- Acted for Ali in its investments in industries including new retail, online second-hand automobile dealing, and e-commerce
- Acted for Ant Financial in its investments in various TMT and technology companies and in its technology cooperation with Apple Inc.
- Acted for CICC in its investment in hospitals, TMT companies and pharmaceutical companies
- Acted for Goldman Sachs in its disposition of a stake in an educational services provider in the PRC and its pre-IPO investment in an electric scooter manufacturer, which is currently listed in the Main Board of the Hong Kong Stock Exchange
- Advised Morgan Stanley on: (i) its disposition of its shares in Huangjihuang, a restaurant chain operator in China, to Yum China, and a shopping mall developer； (ii) its acquisition of a telecom service provider in Hong Kong； and (iii) its establishment of a joint venture with a Hong Kong-listed company, and the joint venture’s acquisition of majority interest in two hospitals in China
- Acted for Yunfeng Capital in its investments in various TMT companies providing logistics or financial services, AI and e-commerce
- Acted for Sequoia in its investments in financial services, bio-tech and e-commerce companies
- Acted for HOPU Fund in its investment in a Hong Kong-listed airport operator and in its privatization of a logistics company
- Acted for Boyu in its investment in an online education services provider, a long-term apartment operator and a reinsurance company
- Acted for Warburg Pincus in its investment in TMT, e-commerce and software companies
- Represented Forebright in its subscription of a convertible note issued by a NASDAQ-listed dairy company and acquisition (together with ORIX) of a majority stake in a financial leasing company
- Acted for ORIX for its investment in an energy storage system manufacturer and in financial leasing and internet financing companies
- Acted for General Atlantic in its subscription of preferred shares issued by an online group-buying company based in China
- Represented Titan Gas Technology in its reverse takeover of a company listed on the Main Board of the Hong Kong Stock Exchange
- Acted for Actis and CDH in their respective dispositions of stakes in Chinese restaurant chains
- Represented various China-based apparel companies in their acquisitions of brands and businesses outside of China
- Represented Cinda International in its cross-border investments in energy, mining and agriculture sectors
- Assisted listed companies in pharmaceutical, entertainment and financial industries with internal investigations into FCPA compliance, listing rules compliance and other compliance issues
- Acted for major bank in compliance investigations
- Represented major multinational chemical, financial, agricultural and healthcare companies in their businesses and operations in China
